🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SPATT Faculty Candidate Seminar *Vikas Anathy, PhD* April 14th at 11AM - mailchi.mp/547a72bf6b3c/u…

SPATT Faculty Candidate Seminar *Vikas Anathy, PhD* TODAY at 11AM - mailchi.mp/87e9123d166d/u…

Do you need a second COVID booster? ‘It depends,’ E. John Wherry and one of the study’s authors, explained what this means for people eligible for another booster and the implications for others. whyy.org/articles/secon…

Registration is Open! | IFI 'Year In Review' Symposium, 5/26 - mailchi.mp/upenn/reminder…

Dirk Trauner appointed Penn Integrates Knowledge University Professor penntoday.upenn.edu/news/dirk-trau…

There are still many questions left to answer about COVID-19 vaccines and immunology, said E. John Wherry cnn.com/2022/05/20/hea…

Last month, E. John Wherry, along with researchers, physicians, and biotech representatives sent a letter to the FDA urging the agency to monitor T cells. scientificamerican.com/article/what-d…

Epigenome Editing Decreases Alcohol Seeking and Anxiety in Rats the-scientist.com/news-opinion/e…

COVID-19 vaccines tweaked to better match today’s #omicron threat are expected to roll out in a few weeks, but still up in the air is how much benefit the boosters will offer, who should get one—and how soon. E. John Wherry discussed the vaccines in The Associated Press. spr.ly/6016Myw36

F.D.A. Authorizes Updated Covid Booster Shots Targeting Omicron Subvariants E. John Wherry nytimes.com/2022/08/31/us/…

Adjusting to Back to School While Prioritizing Family Well being - E. John Wherry pennmedicine.org/news/news-blog… via Penn Medicine

E. John Wherry spoke about what people need to know about the new COVID-19 booster shots whyy.org/episodes/the-n…

Very excited to announce a new transformative gift to UPenn #Immunology to fight autoimmunity. Generous support from Judy and Stewart Colton will enable major new efforts to wage a "war on autoimmunity" using #ImmuneHealth and great science. pennmedicine.org/news/news-rele…

Can Common Infections Trigger Lifelong Health Conditions? It’s Possible, New Studies Suggest - E. John Wherry who was not involved in the research, commented on the findings. pennmedicine.us1.list-manage.com/track/click?u=…

This #WorldCancerDay we celebrate the commitment of our #PICINetwork to create a future without cancer. Through research, partnerships and other efforts, we are accelerating the development of breakthrough therapies for patients. bit.ly/3wWlXpw

Five things to know about this year’s ‘tripledemic’ E. John Wherry Hensley Lab penntoday.upenn.edu/news/five-thin…

Congratulations to Ian Blair (PennSysPharmATT), recipient of the 2023 Pharmacia ASPET Award for Experimental Therapeutics in recognition of his contributions to translational pharmacology, drug metabolism & id'ing key biomarkers for human disease!🎉 bit.ly/3Hmc5dv

Congratulations to E. John Wherry (PennSysPharmATT/ Institute for Immunology and Immune Health (I3H)/ Wherry Lab) on his 2023 election to the American Academy of Arts & Sciences!🎉 American Academy of Arts & Sciences bit.ly/3V0BPm7

#JI_TopRead from PennSysPharmATT Institute for Immunology and Immune Health (I3H) ITMAT Madhu Golla Penn Medicine Proenzyme form of #complementFactorD has intrinsic enzymatic activity does not require MASP3 for activation #ReadTheJI #immunology #complement 👉ow.ly/bwGY50Ofkh9

#Immunotherapy advancements are revolutionizing healthcare by harnessing the immune system's diverse capabilities. #CARTcelltherapy has paved the way, with Penn Medicine at the forefront of these transformative efforts. spr.ly/6017Pc3fB